Breakout Companies
Full Portfolio
- PHANTOM NEUROBringing natural control to robotic systems with AI-powered systems
- EPANA BIOAdvancing autoimmune care with precision therapies guided by genomics and AI
- COPERNIC CATALYSTSDesigning catalysts for drop-in chemicals using physics-based computation
- NOETIKLeveraging advanced machine learning to develop cancer immunotherapies
- ENPLUSONE BIOHarnessing the power and flexibility of enzymes to deliver RNA to the world
- CYTOVALEClinical diagnostics to measure biophysical markers of single cells
- IMMUSOFTEngineering B cells to create protein-producing therapeutics in the body
- VITRA LABSReimagining the future of fertility with hormone-free IVF
- ZYMOCHEMManufacturing sustainable, bio-based products with increased yields
- A-ALPHA BIOAccelerating drug discovery through millions of protein-protein interactions
- PASSKEY THERAPEUTICSDiscovering multifunctional drugs using advanced computation
- CANAERYDecoding the hidden world of scent with a nose-computer interface
- SURF BIOStabilizing biologics to address drug delivery’s core challenge
- TWELVETransforming carbon dioxide emissions into useful chemicals
- PARALLEL BIOPutting the immune system in a dish to improve drug discovery
- CHECKERSPOTLeveraging synthetic biology to produce novel microalgae-derived oils
- INCENDIA THERAPEUTICSReprogramming the tumor microenvironment to treat recalcitrant tumors
- SHIRATRONICSDefeating migraine headaches with minimally invasive neuromodulation
- CELLCHORUSAnalyzing single cells at high throughput to improve cell therapies
- TFC THERAPEUTICSTargeting foundational cancer cells to identify new therapeutic avenues
- ECOVATIVE DESIGNDriving plant-based meats, packaging, and textiles with mycelium
- MODERN MEADOWBuilding enhanced functionality through biofabrication
- STRM.BIOHarnessing extracellular vesicles to deliver gene therapies in-vivo
Previously
Breakout Labs
This isn’t our first rodeo. As founders of Breakout Labs at the Thiel Foundation, we have a long history of investing in and coalescing the ecosystem for early-stage, deep science companies.
